0001493152-23-002021.txt : 20230120
0001493152-23-002021.hdr.sgml : 20230120
20230120160555
ACCESSION NUMBER: 0001493152-23-002021
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230118
FILED AS OF DATE: 20230120
DATE AS OF CHANGE: 20230120
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Meckler Jeffrey A
CENTRAL INDEX KEY: 0001506916
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40652
FILM NUMBER: 23541009
MAIL ADDRESS:
STREET 1: 740 BROADWAY
STREET 2: 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10003
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Indaptus Therapeutics, Inc.
CENTRAL INDEX KEY: 0001857044
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 863158720
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3 COLUMBUS CIRCLE
STREET 2: 15TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
BUSINESS PHONE: (646) 427-2727
MAIL ADDRESS:
STREET 1: 3 COLUMBUS CIRCLE
STREET 2: 15TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
FORMER COMPANY:
FORMER CONFORMED NAME: Intec Parent Inc.
DATE OF NAME CHANGE: 20210414
4
1
ownership.xml
X0306
4
2023-01-18
0
0001857044
Indaptus Therapeutics, Inc.
INDP
0001506916
Meckler Jeffrey A
C/O INDAPTUS THERAPEUTICS, INC.
3 COLUMBUS CIRCLE, 15TH FLOOR
NEW YORK
NY
10019
1
1
0
0
CEO and Director
Stock Option (Right to Buy)
1.61
2023-01-18
4
A
0
100000
0
A
2033-01-18
Common Stock
100000
100000
D
The stock option vests and becomes exercisable as to one-third of the total shares on January 18, 2024 and thereafter in equal quarterly installments over the following 24 months, such that the stock option becomes vested and exercisable as to all shares on January 18, 2026.
/s/ Jeffrey Meckler
2023-01-20